 HYDERABAD, India--BUSINESS WIRE--Dr. Reddys Laboratories Ltd. BSE: 500124 NSE: DRREDDY NYSE: RDY NSEIFSC: DRREDDY today announced its consolidated financial results for the quarter and the nine months ended December 31, 2020. The information mentioned in this release is on the basis of consolidated financial statements under International Financial Reporting Standards IFRS. Q3 Performance Summary 9M Performance Summary Rs. 4,930 Cr Rs. 14,244 Cr Revenue Revenue Up: 12 YoY; 1 